focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHerald Regulatory News (HRI)

Share Price Information for Herald (HRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,180.00
Bid: 2,180.00
Ask: 2,190.00
Change: -35.00 (-1.58%)
Spread: 10.00 (0.459%)
Open: 2,220.00
High: 2,220.00
Low: 2,180.00
Prev. Close: 2,215.00
HRI Live PriceLast checked at -
Herald is an Investment Trust

To achieve capital appreciation through investments in smaller quoted companies in the areas of telecommunications, multimedia and technology.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of non-executive director

13 Dec 2023 07:00

RNS Number : 5306W
Herald Investment Trust PLC
13 December 2023
 

 

Herald Investment Trust plc (the "Company" or "Herald")

 

LEI number: 213800U7G1ROCTJYRR70

 

 

Appointment of Priya Guha MBE as a non-executive director

 

Following a comprehensive selection process, conducted using an independent third-party search firm, the Company is pleased to announce the appointment of Priya Guha MBE as an independent non-executive director of the Company with immediate effect.

 

Priya has a portfolio of roles across the global and UK technology and innovation landscape including as a non-executive director at UK Research & Innovation and Digital Catapult, a venture partner at Merian Ventures, a San Francisco based venture capital fund, and an advisor to various start-up companies including Kheiron Medical Technologies and Gallos Technologies. She is also a non-executive director at Reach PLC.

 

Priya was awarded an MBE in 2021 for services to international trade and women in innovation. Priya holds a BA in Social and Political Sciences from the University of Cambridge.

 

There is no other information required to be disclosed under section 9.6.13 of the Listing Rules in respect of Priya Guha.

 

Andrew Joy, Chairman of Herald, said: "Herald Investment Trust invests in smaller quoted companies in the technology and communications sectors, in the UK and internationally. Priya brings knowledge of the global technology sector, and valuable experience in both public and private sectors, to the Board at a time when it is as essential as ever that the UK Stock Exchange remains an effective market for smaller tech companies."

 

13 December 2023

 

About Herald Investment Trust

 

Herald Investment Trust invests globally in the excellent opportunities available in the smaller quoted technology and communications sectors. The Company was established in 1994 and raised £65 million on launch and a further £30 million in 1996. No further capital has been raised. 

Since inception Herald has delivered a 22x NAV total return - with the NAV per share, on a total return basis, having compounded at an annualised rate of 11.0%. Herald has grown to become a constituent of the FTSE 250 index with total assets of approximately £1.1 billion. The Company is currently ungeared and has also returned in excess of £300 million to shareholders through share buy backs - a multiple of its original capital.

The Board believes that this outstanding performance is primarily attributable to the Company's distinctive investment strategy which is focused entirely on smaller quoted companies in the global technology and communications sectors. This strategy requires specialist expertise, an extensive network and sound investment judgement from the Investment Manager. Target companies within the Company's investible universe often receive very limited institutional investor participation, creating opportunities for the Investment Manager to find excellent companies at attractive valuations, and to support them as they grow.

HIT occupies a unique position as the only investment trust offering expert access to such a wide range of small and micro technology and communications stocks to both retail investors and institutions, and performs a vital (and very successful) role in enabling the returns from such companies to be shared by a wide range of investors.

Since inception, the Company has invested approximately £660 million of primary capital, of which over £500 million has been invested in UK listed and AIM companies. In addition to providing outstanding returns to shareholders, the Company's initial capital has been reinvested multiple times providing much needed capital to a growth sector of the UK economy, helping to build businesses, create skilled jobs and enhance the UK's productivity. Of the total profits of approximately £1.4 billion made by the Company since 1994, over £900 million is attributable to UK listed investments and AIM stocks.

 

 

For further information contact:

 

 

Apex Listed Companies Services (UK) Limited

020 3327 9720

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZMMZKZMGFZM
Date   Source Headline
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 202411:18 amRNSNet Asset Value(s)
22nd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSFinal Results
21st Feb 202411:18 amRNSNet Asset Value(s)
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 202411:38 amRNSNet Asset Value(s)
19th Feb 202411:41 amRNSNet Asset Value(s)
19th Feb 20249:02 amRNSHolding(s) in Company
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 202411:19 amRNSNet Asset Value(s)
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 202411:08 amRNSNet Asset Value(s)
15th Feb 202410:52 amRNSStatistics and Performance Report
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 202411:18 amRNSNet Asset Value(s)
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 202411:09 amRNSNet Asset Value(s)
9th Feb 202411:19 amRNSNet Asset Value(s)
8th Feb 202411:19 amRNSNet Asset Value(s)
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 202411:50 amRNSNet Asset Value(s)
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:32 amRNSNet Asset Value(s)
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20241:22 pmRNSNet Asset Value(s)
2nd Feb 202412:01 pmRNSNet Asset Value(s)
1st Feb 20242:23 pmRNSNet Asset Value(s)
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 202411:45 amRNSNet Asset Value(s)
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 202411:45 amRNSNet Asset Value(s)
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 202411:30 amRNSNet Asset Value(s)
26th Jan 202411:44 amRNSNet Asset Value(s)
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 202411:36 amRNSNet Asset Value(s)
25th Jan 202410:50 amRNSCompliance with Market Abuse Regulation
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 202412:26 pmRNSStatistics and Performance Report
24th Jan 202411:33 amRNSNet Asset Value(s)
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 202411:38 amRNSNet Asset Value(s)
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 202411:57 amRNSNet Asset Value(s)
19th Jan 20245:53 pmRNSTransaction in Own Shares
19th Jan 202411:15 amRNSNet Asset Value(s)
18th Jan 202411:33 amRNSNet Asset Value(s)
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 202411:16 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.